These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3006 related articles for article (PubMed ID: 7620344)

  • 1. Ganglioside profiles of experimental melanomas and of their melanosomal fractions.
    Vedralová E; Borovanský J; Hach P
    Melanoma Res; 1995 Apr; 5(2):87-92. PubMed ID: 7620344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosphingolipids in Bomirski transplantable melanomas in hamsters.
    Ren SL; Slominski A; Yu RK
    Cancer Res; 1989 Dec; 49(24 Pt 1):7051-6. PubMed ID: 2582447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gangliosides of human melanoma.
    Tsuchida T; Saxton RE; Morton DL; Irie RF
    J Natl Cancer Inst; 1987 Jan; 78(1):45-54. PubMed ID: 3467129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the gangliosides GM3, GD3 and GD2 in tissue sections of normal skin, naevi, primary and metastatic melanoma.
    Hersey P; Jamal O; Henderson C; Zardawi I; D'Alessandro G
    Int J Cancer; 1988 Mar; 41(3):336-43. PubMed ID: 3346097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common phenotypic expression of gangliosides GM3 and GD3 in normal human tissues and neoplastic skin lesions.
    Nakakuma H; Horikawa K; Kawaguchi T; Hidaka M; Nagakura S; Hirai S; Kageshita T; Ono T; Kagimoto T; Iwamori M
    Jpn J Clin Oncol; 1992 Oct; 22(5):308-12. PubMed ID: 1469793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3.
    Ren S; Ariga T; Scarsdale JN; Zhang Y; Slominski A; Livingston PO; Ritter G; Kushi Y; Yu RK
    J Lipid Res; 1993 Sep; 34(9):1565-72. PubMed ID: 8228639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ganglioside GM3:GD3 ratio as an index for the management of melanoma.
    Ravindranath MH; Tsuchida T; Morton DL; Irie RF
    Cancer; 1991 Jun; 67(12):3029-35. PubMed ID: 2044049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganglioside antigens in tissue sections of skin, naevi, and melanoma--implications for treatment of melanoma.
    Hersey P
    Cancer Treat Res; 1991; 54():137-51. PubMed ID: 1673856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Melanoma-associated gangliosides in the fish genus Xiphophorus.
    Felding-Habermann B; Anders A; Dippold WG; Stallcup WB; Wiegandt H
    Cancer Res; 1988 Jun; 48(12):3454-60. PubMed ID: 3370642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside expression on human malignant melanoma assessed by quantitative immune thin-layer chromatography.
    Hamilton WB; Helling F; Lloyd KO; Livingston PO
    Int J Cancer; 1993 Feb; 53(4):566-73. PubMed ID: 8436430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ganglioside GD3 shedding by human malignant melanoma cells.
    Bernhard H; Meyer zum Büschenfelde KH; Dippold WG
    Int J Cancer; 1989 Jul; 44(1):155-60. PubMed ID: 2744885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variations in the ganglioside profile of uveal melanoma correlate with cytologic heterogeneity.
    Kanda S; Cochran AJ; Lee WR; Morton DL; Irie RF
    Int J Cancer; 1992 Nov; 52(5):682-7. PubMed ID: 1428227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A purified GM3 ganglioside conjugated vaccine induces specific, adjuvant-dependent and non-transient antitumour activity against B16 mouse melanoma in vitro and in vivo.
    Carr A; Mazorra Z; Alonso DF; Mesa C; Valiente O; Gomez DE; Perez R; Fernandez LE
    Melanoma Res; 2001 Jun; 11(3):219-27. PubMed ID: 11468510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of tumor cell vaccine after incorporating monophosphoryl lipid A (MPL) in tumor cell membranes containing tumor-associated ganglioside.
    Ravindranath MH; Brazeau SM; Morton DL
    Experientia; 1994 Jul; 50(7):648-53. PubMed ID: 8033972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
    Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
    J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different sensitivities of the murine melanomas BL-6 and BL-6-beta m to local injections of interleukin-2 (IL-2). Analysis of gangliosides after the treatment.
    Nakayama J; Tsuchida T; Toyofuku K; Shimokawa-Kuroki R; Taniguchi S; Hori Y
    Melanoma Res; 1994 Oct; 4(5):297-302. PubMed ID: 7858413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel hydrophobized GM3 ganglioside/Neisseria meningitidis outer-membrane-protein complex vaccine induces tumor protection in B16 murine melanoma.
    Alonso DF; Gabri MR; Guthmann MD; Fainboim L; Gomez DE
    Int J Oncol; 1999 Jul; 15(1):59-66. PubMed ID: 10375594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GD3, a prominent ganglioside of human melanoma. Detection and characterisation by mouse monoclonal antibody.
    Pukel CS; Lloyd KO; Travassos LR; Dippold WG; Oettgen HF; Old LJ
    J Exp Med; 1982 Apr; 155(4):1133-47. PubMed ID: 7061953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin.
    Ravindranaths MH; Paulson JC; Irie RF
    J Biol Chem; 1988 Feb; 263(4):2079-86. PubMed ID: 3339003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The addition of exogenous gangliosides to cultured human cells results in the cell type-specific expression of novel surface antigens by a biosynthetic process.
    Furukawa K; Thampoe IJ; Yamaguchi H; Lloyd KO
    J Immunol; 1989 Feb; 142(3):848-54. PubMed ID: 2464027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 151.